1	3 The delayed PEDIARIX use clinic cohort will include all infants from SCKP who during the enrollment period for the primary cohort began their primary course of vaccination with DTaP vaccine and for whom at least one dose of DTaP vaccine was co-administered with Prevnar prior to the infant 's 9-|DTaP vaccine[179,191]||||||||||139057|139057|dtap vaccine
1	3 The delayed PEDIARIX use clinic cohort will include all infants from SCKP who during the enrollment period for the primary cohort began their primary course of vaccination with DTaP vaccine and for whom at least one dose of DTaP vaccine was co-administered with Prevnar prior to the infant 's 9-|Prevnar[264,271]||||||||||798236|798220|streptococcus pneumoniae serotype 14 capsular antigen diphtheria crm197 protein conjugate vaccine
1	3 The delayed PEDIARIX use clinic cohort will include all infants from SCKP who during the enrollment period for the primary cohort began their primary course of vaccination with DTaP vaccine and for whom at least one dose of DTaP vaccine was co-administered with Prevnar prior to the infant 's 9-|DTaP vaccine[226,238]||||||||||139057|139057|dtap vaccine
2	month birthday and safety follow-up information is available The size of this cohort will depend on how quickly individual SCKP clinics and medical centers use PEDIARIX once it is made available The size of this cohort therefore is not immediately predictable|PEDIARIX[457,465]|||||||||C1170508|352877|763096|poliovirus vaccine inactivated, type 1 (mahoney)
